Quiet on the insider front: nobody at Chimera Investment Corp bought or sold CIM shares in open-market trades this past year.
Big money check: 195 institutions held CIM as of Q2 2026, and more funds bought than sold. No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | CREAGH GERARD | Director | Buy | 12,500 | $13.31 | $166K | SEC |
| Dec 12, 2024 | Macdowell Jack Lee Jr | Executive Officer | Buy | 66,000 | $15.13 | $999K | SEC |
| Dec 9, 2024 | Macdowell Jack Lee Jr | Executive Officer | Buy | 50,000 | $14.91 | $746K | SEC |
| Dec 9, 2024 | Macdowell Jack Lee Jr | Executive Officer | Buy | 50,000 | $14.70 | $735K | SEC |
| Jun 18, 2024 | CREAGH GERARD | Director | Buy | 10,000 | $13.07 | $131K | SEC |
There were no open-market insider trades in CIM in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
195 investment managers reported holding CIM in SEC Form 13F filings for Q2 2026.
No congressional trades in CIM were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).